These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 17409018

  • 1. Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
    Calanca LN, Fehr T, Jochum W, Fischer-Vetter J, Müllhaupt B, Wüthrich RP, Ambühl PM.
    J Clin Virol; 2007 May; 39(1):54-8. PubMed ID: 17409018
    [Abstract] [Full Text] [Related]

  • 2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 May; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.
    Brillanti S, Levantesi F, Masi L, Foli M, Bolondi L.
    Hepatology; 2000 Sep; 32(3):630-4. PubMed ID: 10960460
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N, Ribes D, Izopet J, Rostaing L.
    Transplantation; 2006 Oct 15; 82(7):853-6. PubMed ID: 17038897
    [Abstract] [Full Text] [Related]

  • 6. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
    Fujita N, Kaito M, Kai M, Sugimoto R, Tanaka H, Horiike S, Konishi M, Iwasa M, Watanabe S, Adachi Y.
    J Viral Hepat; 2006 Jul 15; 13(7):441-8. PubMed ID: 16792537
    [Abstract] [Full Text] [Related]

  • 7. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
    Jain AB, Eghtesad B, Venkataramanan R, Fontes PA, Kashyap R, Dvorchik I, Shakil AO, Kingery L, Fung JJ.
    Liver Transpl; 2002 Nov 15; 8(11):1007-13. PubMed ID: 12424713
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus infection in haemodialysis and kidney transplant patients.
    Baid-Agrawal S, Pascual M, Moradpour D, Frei U, Tolkoff-Rubin N.
    Rev Med Virol; 2008 Nov 15; 18(2):97-115. PubMed ID: 18064722
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].
    Kamar N, Sandres-Saune K, Selves J, Durand D, Izopet J, Rostaing L.
    Nephrologie; 2003 Nov 15; 24(2):89-94. PubMed ID: 12723514
    [Abstract] [Full Text] [Related]

  • 12. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M, Fernández Lucas M, Echarri R, Teruel JL, Alarcón C, Merino JL, Ortuño J.
    Nefrologia; 2004 Nov 15; 24 Suppl 3():39-42. PubMed ID: 15219067
    [Abstract] [Full Text] [Related]

  • 13. Role of amantadine and other adjuvant therapies in the treatment of hepatitis C.
    Brillanti S.
    Semin Liver Dis; 2004 Nov 15; 24 Suppl 2():89-95. PubMed ID: 15346251
    [Abstract] [Full Text] [Related]

  • 14. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
    Terrault NA, Adey DB.
    Clin J Am Soc Nephrol; 2007 May 15; 2(3):563-75. PubMed ID: 17699464
    [Abstract] [Full Text] [Related]

  • 15. Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-alpha and/or ribavirin.
    Di Martino V, Boudjema H, Delacour T, Cazier A, Caron C, Coutarel P, Dumouchel P, Cadranel JF.
    Clin Infect Dis; 2001 Mar 01; 32(5):830-1. PubMed ID: 11229855
    [Abstract] [Full Text] [Related]

  • 16. Treatment of HCV in patients with renal failure.
    Kalia H, Lopez PM, Martin P.
    Arch Med Res; 2007 Aug 01; 38(6):628-33. PubMed ID: 17613354
    [Abstract] [Full Text] [Related]

  • 17. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B, Jung MC, Schirren CA, Loehe F, Thiel M, Nitschko H, Diepolder H, Ulsenheimer A, Heeg M, Zachoval R, Gruener NH.
    Eur J Gastroenterol Hepatol; 2008 Aug 01; 20(8):778-83. PubMed ID: 18617783
    [Abstract] [Full Text] [Related]

  • 18. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
    Kamar N, Boulestin A, Selves J, Esposito L, Sandres-Saune K, Stébenet M, Chatelut E, Durand D, Rostaing L, Izopet J.
    J Med Virol; 2005 May 01; 76(1):61-8. PubMed ID: 15778976
    [Abstract] [Full Text] [Related]

  • 19. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
    Mihm U, Grigorian N, Welsch C, Herrmann E, Kronenberger B, Teuber G, von Wagner M, Hofmann WP, Albrecht M, Lengauer T, Zeuzem S, Sarrazin C.
    Antivir Ther; 2006 May 01; 11(4):507-19. PubMed ID: 16856625
    [Abstract] [Full Text] [Related]

  • 20. Amantadine in the treatment of patients with chronic hepatitis C.
    Foster GR.
    Ital J Gastroenterol Hepatol; 1998 Dec 01; 30(6):614-5. PubMed ID: 10076784
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.